Boston Scientific
BSX
BSX
874 hedge funds and large institutions have $48.1B invested in Boston Scientific in 2022 Q2 according to their latest regulatory filings, with 80 funds opening new positions, 324 increasing their positions, 319 reducing their positions, and 92 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
3% less funds holding
Funds holding: 900 → 874 (-26)
13% less first-time investments, than exits
New positions opened: 80 | Existing positions closed: 92
15% less capital invested
Capital invested by funds: $56.8B → $48.1B (-$8.73B)
Holders
874
Holding in Top 10
21
Calls
$312M
Puts
$313M
Top Buyers
| 1 | +$278M | |
| 2 | +$271M | |
| 3 | +$232M | |
| 4 |
Morgan Stanley
New York
|
+$229M |
| 5 |
Millennium Management
New York
|
+$186M |
Top Sellers
| 1 | -$565M | |
| 2 | -$174M | |
| 3 | -$132M | |
| 4 |
Goldman Sachs
New York
|
-$128M |
| 5 |
Two Sigma Advisers
New York
|
-$116M |